Cow's milk protein allergy and possible means for its prevention

Nutrition

Volumn 17, Issue 7-8, 2001, Pages 642-651

  Exl, Bianca Maria ^a   Fritsché, Rodolphe ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; MILK PROTEIN; NUTRAMIGEN; UNCLASSIFIED DRUG;

ARTIFICIAL MILK; ATOPY; BREAST FEEDING; DIET; HUMAN; HYDROLYSIS; MILK ALLERGY; NONHUMAN; NUTRITION; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; REVIEW;

ANIMALS; BREAST FEEDING; CATTLE; FEMALE; HUMANS; HYDROLYSIS; INFANT; INFANT FOOD; INFANT, NEWBORN; MILK HYPERSENSITIVITY; MILK PROTEINS;

EID: 0034941083     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(01)00566-4     Document Type: Review

References (159)

1. Does breast-feeding affect the infant's immune responsiveness?
2. Normal microbial flora of the gut and the immune system
3. Studies on breast-feeding and infections. How good is the evidence?
4. Protective effect of breastfeeding against infection
5. The relationship between breast-feeding and early childhood morbidity in a general population
6. Comparative study of infant morbidity in breast-fed and formula-fed infants in developed countries
7. Prevalence of allergic diseases in school children in relation to family history, upper respiratory infections, and residential characteristics
8. Prevalence of allergic disorders in early infancy
9. The prevalence of and risk factors for atopy in early childhood; a whole population birth cohort study
10. Increase in asthma, allergic rhinitis and eczema in Swedish school children between 1979-1991
11. Epidemiology. Prevalence of allergic diseases. Allergic diseases as a public health problem
12. Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life
13. Immediate reactions to foods in infants and children
14. Cow milk allergy in infancy and early childhood
15. Emerging disease profiles in infants and young children with food allergy
16. The Melbourne milk allergy study-two decades of clinical research
17. A prospective study of cow's milk allergy in exclusively breastfed infants. Incidence, pathogenic role of early inadvertent exposure to cow's milk formula, and characterization of bovine milk protein in human milk
18. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy; a prospective study of 6209 infants
19. The natural history of cow's milk allergy/intolerance
20. A prospective study of cow's milk allergy in Danish infants during the first 3 years of life
21. Genetic aspects of atopic allergy
22. Genetic aspects and possible causes of increase in allergic diseases
23. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children; the International Study of Asthma and Allergies in Childhood (ISSAC)
24. Atopic versus infectious diseases in childhood; a question of balance?
25. Development of the immune system in atopic children
26. Why atopic diseases prevail in developed countries
27. Normal microbial flora of the gut and the immune system
28. The hygiene hypothesis revised; is the rising frequency of allergy due to changes in the intestinal flora?
29. Establishment of a normal intestinal flora in the newborn infant
30. Immune effects of probiotics
31. Cow's milk allergens-An update on allergens
32. Cow's milk protein allergy and intolerance in infancy. Some clinical, epidemiological and immunological aspects
33. A low allergen diet is a significant intervention in infantile colic; result of a community based study
34. Gastroesophageal reflux and cow's milk allergy in infants; a prospective study
35. Some limitations of double-blind placebo-controlled food challenges in young children
36. The management of food allergy
37. Factitious food allergy and failure to thrive
38. Low serum cholesterol in children with food allergy
39. Subclinical iron deficiency in children with food allergy
40. Evidence for mild protein malnutrition in children with food allergy
41. Which formula in cow's milk protein intolerance? The dietitian's dilemma
42. Adverse food reactions in patients with grass pollen allergic respiratory disease
43. Natural history of sensitisations in atopic dermatitis; a 3-year follow-up in 250 children-food allergy and high risk of respiratory symptoms
44. Role of food allergy in serous otitis media
45. Importance of food allergy in atopic dermatitis
46. Epidemiology and natural history of atopic dermatitis
47. Atopic eczema and other manifestations of atopy; results of a study in East and West Germany
48. Atopic dermatitis and food allergy in Europe-prevalence and risk factors
49. Atopic dermatitis in 5-6 year old Swedish children; cumulative incidence, point prevalence and severity scoring
50. Allergy, asthma and immunology from infancy to adulthood
51. Natural history of atopic disease in early childhood; is cord blood IgE a prognostic factor?
52. From food allergy and atopic dermatitis to respiratory allergy
53. Verlauf der atopischen Dermatitis nach dem Kleinkindalter
54. Uptake and transport of macromolecules by the intestine: possible role in clinical disorders: an update
55. Das Phänomen der Persorption und seine Bedeutung für allergologische Fragestellungen
56. Immune mechanisms of peripheral tolerance
57. Importance of milk and diet on the ontogeny and adaption of the intestine
58. Bovine beta-lactoglobulin in human milk from atopic and non-atopic mothers. Relationship to maternal intake of homogenised and unhomogenised milk
59. Immunologische Aspekte bei der Ernährung mit Muttermilch
60. Oral tolerance; Immune responses to food allergens
61. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding
62. Regulation of the immune respones to oral administration of antigens in food allergic experimental animals
63. History of oral tolerance and mucosal immunity
64. Induction of oral tolerance to cow's milk proteins in rats fed with protein hydrolysate
65. Induction of systemic immunological tolerance to beta-lactoglobulin by oral administration of a whey protein hydrolysate
66. Peptides obtained by tryptic hydrolysis of bovine beta-lactoglobulin induce specific oral tolerance in mice
67. Allergens in mother's milk; tolerisation or sensitization?
68. Genetics of atopy
69. Development of immune functions related to allergic mechanisms in young children
70. Genetic aspects of atopic allergy
71. Development of the immune system in atopic children
72. Predictors of atopy in newborn babies
73. Predictability of early atopy by cord-blood IgE and parental history
74. Early life markers of atopy and asthma
75. The atopic career in childhood-the German multicentre atopy study (MAS 90)
76. The influence of breastfeeding and artificial feeding in infantile eczema
77. Socio-economic costs of allergic diseases
78. Five-year follow-up of high risk infants with family history of allergy, exclusively breast-fed or fed partial hydrolysate, soy or conventional cow's milk formula
79. Prevention of atopic diseases
80. Hydrolyzed cow's milk formulae. Allergenicity and use in treatment and prevention. An ESPACI position paper
81. Dietary restrictions during pregnancy
82. Allergy prevention by maternal elimination during late pregnancy-a 5-year follow-up of a randomized study
83. Immune response of the atopic woman and foetus; effects of high- and low-dose food allergen intake during late pregnancy
84. The immunological and long-term atopic outcome of infants born to women following a milk-free diet during late pregnancy and lactation; a pilot study
85. Influence of maternal allergen avoidance during pregnancy and lactation on incidenc of atopic eczema in infants
86. Reduced interferon-gamma secretion in neonates is associated with the subsequent development of atopy
87. Is deficiency of interferon-gamma production by allergen triggered cord blood cells a predictor of atopic eczema?
88. Cord blood lymphocyte responses to food antigens for the prediction of allergic disorder
89. Immune tolerance produced by pre- and postnatal exposure to dietary antigens
90. Breastfeeding provides passive and likely long-lasting immunity
91. Cow's milk intolerance in infants under 1 year of age; a prospective epidemiological study
92. Breastfeeding of allergic infants
93. Does breastfeeding help protect against atopic disease? Biology, methodology, and a golden jubilee of controversy
94. Early intervention for the prevention of atopic dermatitis
95. Natural history and prevention of food hypersensitivity
96. Allergy prevention-an attainable objective?
97. Early solid feeding and recurrent childhood eczema; a 10-year longitudinal study
98. The effect of hypo-allergenic formulae in infants at risk of allergic disease
99. Breastfeeding as prophylaxis against atopic disease; prospective follow-up study until 17 years old
100. Association between breast feeding and asthma in 6 year old children; findings of a prospective birth cohort study
101. Early diet of preterm infants and development of allergic or atopic disease; randomized prospective study
102. The development and prediction of atopy in high-risk children; follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance
103. Effects of maternal dietary avoidance during lactation on allergy in children at 10 years of age
104. Use of infant formulas in infants with cow's milk allergy. A review and recommendation
105. Reduction of whey protein allergenicity by processing
106. Whey protein allergenicity and its reduction by technological means
107. Comment on antigen-reduced infant formulae
108. Control of hypoallergenicity by animal models
109. In utero induction of oral tolerance in rats; antigen feeding during pregnancy downregulates specific IgE response in offsprings
110. Hydrolyzed cow's milk formulae
111. Dietary products used in infants for treatment and prevention of food allergy
112. Hypoallergenic infant formulas
113. The lessons of non-interventional and interventional prospective studies on the development of atopic disease during childhood
114. Use of immunoblotting and monoclonal antibodies to evaluate the residual antigenic activity of milk protein hydrolyzed formulae
115. Food processing approaches to altering allergenic potential of milk based formula
116. Strategies for prevention. Results of prevention programmes
117. Nutritional evaluation of protein hydrolysate formulae
118. Influence of maternal diet during lactation and use of formula feeds on the development of atopic eczema in high risk infants
119. Effect of an allergy prevention program on incidence of atopic symptoms in infancy
120. Allergen avoidance in infancy and allergy at 4 years of age
121. Effect of combined maternal and infant food allergen avoidance on the development of atopy in early infancy; a randomized study
122. Primary and secondary prevention of atopic diseases in children
123. The development and prediction of atopy in high-risk children; follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance
124. Parenteral and oral administration of tolerogens; protein-IgG Conjugates
125. Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases
126. Alimentary allergy prevention in infants with familial increased allergic risk; the effect of different feeding regimens in the first 6 month on atopic manifestations during the first year of life
127. Effects of a dietary and environmental prevention program on the incidence of allergic symptoms in high atopic risk infants; three year's follow-up
128. The long-term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease
129. Controlled trials investigating the use of one partially hydrolyzed whey formula for dietary prevention of atopic manifestations until 60 months of age; an overview using meta-analytical techniques
130. Prävention bei atopiegefährdeten Säuglingen; eHF besser als pHF?
131. Influence of breast milk, soy and two hydrolyzed formulas on the development of allergic manifestations in infants at risk
132. Extensively and partially hydrolyzed infant formulas for allergy prophylaxis
133. Cow's milk IgE and IgG antibody responses to cow's milk formulae
134. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention; a prospecitve randomized study
135. Sensitization in atopic predisposed infants fed human milk, an extensively hydrolyzed casein based, an extensively hydrolyzed whey based or partially hydrolyzed whey based formula. A prospective randomized study
136. GINI; German International Nutrition Intervention Program. Design and first data on recrution
137. Improved general health status in an unselected infant population following an allergen reduced dietary intervention program; the ZUFF-study-program. Part I: study design and 6-month nutritional behaviour
138. Improved general health status in an unselected infant population following an allergen reduced dietary intervention program; the ZUFF study program. Part II: infant growth and health status to age 6 months
139. Prostaglandin E2 primes native T cells for the production of antiinflammatory cytokines
140. The causes of the increasing prevalence of allergy. Is atopy a microbial deprivation disorder?
141. Symptomatology and growth in infants with cow's milk protein intolerance using two different whey protein hydrolysate based formulas in primary health care setting
142. Evaluation of a casein and a whey hydrolysate for treatment of cow's milk sensitive enteropathy
143. Prevention of food allergy in high-risk infants until the age of 5 years. A prospective dietary intervention study. XVI. EAACI
144. Effect of allergen avoidance in infancy on allergic manifestations at age two years
145. Genetic and environmental factors affect in the development of atopy through age 4 in children of atopic parents; a prospective randomised study of food allergen avoidance
146. Long term prevention of allergic diseases by using protein hydrolysate formula in at-risk infants
147. Residual antigenicity of hypoallergenic infant formulas and the occurence of milk-specific IgE-antibodies in patients with clinical allergy
148. The importance of peptide lenght in hypoallergenic infant formulae
149. Product development horizons-a view from industry
150. Detection of potentially allergenic material in 12 hydrolysed milk formulas
151. Molecular basis of IgE cross reactivity between human β-casein and bovine β-casein, a major allergen of milk
152. Prevention and management of food allergy